Further Analysis Is Required to Identify an Early Stopping Rule for Peginterferon Therapy That Is Valid for All Hepatitis B e Antigen-Positive Patients Reply

Milan Sonneveld; Vincent Rijckborst; HLA Janssen

doi:10.1002/hep.24182

Further Analysis Is Required to Identify an Early Stopping Rule for Peginterferon Therapy That Is Valid for All Hepatitis B e Antigen-Positive Patients Reply

Milan Sonneveld, Vincent Rijckborst, HLA Janssen

Gastroenterology & Hepatology

Research output: Contribution to journal › Article › Academic › peer-review

Original language	Undefined/Unknown
Pages (from-to)	1055-1055
Number of pages	1
Journal	Hepatology
Volume	53
Issue number	3
DOIs	https://doi.org/10.1002/hep.24182
Publication status	Published - 2011

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1002/hep.24182

http://hdl.handle.net/1765/33787

Cite this

@article{15e636d36bc2473e902e04c44498e9c0,

title = "Further Analysis Is Required to Identify an Early Stopping Rule for Peginterferon Therapy That Is Valid for All Hepatitis B e Antigen-Positive Patients Reply",

author = "Milan Sonneveld and Vincent Rijckborst and HLA Janssen",

year = "2011",

doi = "10.1002/hep.24182",

language = "Undefined/Unknown",

volume = "53",

pages = "1055--1055",

journal = "Hepatology",

issn = "0270-9139",

publisher = "John Wiley & Sons Ltd.",

number = "3",

}

TY - JOUR

T1 - Further Analysis Is Required to Identify an Early Stopping Rule for Peginterferon Therapy That Is Valid for All Hepatitis B e Antigen-Positive Patients Reply

AU - Sonneveld, Milan

AU - Rijckborst, Vincent

AU - Janssen, HLA

PY - 2011

Y1 - 2011

U2 - 10.1002/hep.24182

DO - 10.1002/hep.24182

M3 - Article

SN - 0270-9139

VL - 53

SP - 1055

EP - 1055

JO - Hepatology

JF - Hepatology

IS - 3

ER -